Analyst Reco. 10x Genomics, Inc.

Equities

TXG

US88025U1097

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-08 pm EDT			5-day change	1st Jan Change
18.45 ^USD	-1.44%		-0.75%	-67.03%

Jul. 01	10x Genomics, Inc.(NasdaqGS:TXG) added to Russell Small Cap Comp Value Index	CI
Jul. 01	10x Genomics, Inc.(NasdaqGS:TXG) added to Russell 3000 Value Index	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Barclays Cuts Price Target on 10x Genomics to $24 From $36, Maintains Overweight Rating	Jun. 28	MT
Wolfe Research Downgrades 10x Genomics to Peer Perform From Outperform	Jun. 27	MT
Guggenheim Downgrades 10x Genomics to Neutral From Buy	Jun. 25	MT
Jefferies Initiates 10x Genomics at Hold Rating With $24 Price Target	Jun. 03	MT
UBS Adjusts 10x Genomics Price Target to $30 From $52, Maintains Neutral Rating	May. 01	MT
Canaccord Genuity Adjusts Price Target on 10x Genomics to $50 From $65, Maintains Buy Rating	Apr. 29	MT
Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating	Apr. 18	MT
UBS Adjusts 10x Genomics Price Target to $52 From $44, Maintains Neutral Rating	Feb. 21	MT
Stifel Cuts Price Target on 10x Genomics to $63 From $68, Maintains Buy Rating	Feb. 16	MT
Barclays Adjusts Price Target on 10x Genomics to $55 From $45, Maintains Overweight Rating	Jan. 25	MT
Wolfe Research Initiates 10x Genomics With Outperform Rating With $55 Price Target	Dec. 13	MT
BofA Securities Upgrades 10x Genomics to Neutral From Underperform, Adjusts Price Target to $54 From $36	Dec. 12	MT
UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating	Nov. 07	MT
Barclays Lowers Price Target on 10x Genomics to $47 From $66, Maintains Overweight Rating	23-09-29	MT
Citigroup Adjusts Price Target on 10x Genomics to $75 From $65, Maintains Buy Rating	23-08-04	MT
UBS Adjusts Price Target on 10x Genomics to $62 From $58, Maintains Neutral Rating	23-08-04	MT
Deutsche Bank Adjusts 10x Genomics Price Target to $65 From $56, Maintains Buy Rating	23-08-02	MT
Goldman Sachs Adjusts Price Target on 10x Genomics to $30 From $25, Maintains Sell Rating	23-07-13	MT
Barclays Initiates 10x Genomics at Overweight With $65 Price Target	23-05-10	MT
Stifel Nicolaus Adjusts 10x Genomics Price Target to $68 From $57, Maintains Buy Rating	23-05-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. 10x Genomics, Inc.

Equities

TXG

US88025U1097

Analyst Reco.

Filters